相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review
Hannah Clark et al.
HEART FAILURE REVIEWS (2022)
The EMPEROR-Preserved study: end of the search for the Phoenix or beginning of a new season for trials in heart failure with preserved ejection fraction
Massimo Volpe et al.
EUROPEAN HEART JOURNAL (2021)
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction An Analysis of DAPA-HF
Pardeep S. Jhund et al.
CIRCULATION (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D. Solomon et al.
CIRCULATION (2020)
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Substance and Substrate LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials
Biykem Bozkurt et al.
CIRCULATION (2020)
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction Detailed Phenotypes, Prognosis, and Response to Spironolactone
Jordana B. Cohen et al.
JACC-HEART FAILURE (2020)
Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
Alex Alcaide-Aldeano et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Identifying Phenogroups in patients with subclinical diastolic dysfunction using unsupervised statistical learning
Yvonne E. Kaptein et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure The Need for Further Evidence Generation and Practice Guidelines Optimization
Muhammad Shahzeb Khan et al.
CIRCULATION (2020)
COVID-19 and Heart FailureWith Preserved Ejection Fraction
Priya Mehta Freaney et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial
Paul W. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction The CAPACITY HFpEF Randomized Clinical Trial
James E. Udelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction
David M. Kaye et al.
ESC HEART FAILURE (2020)
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF Results of the Randomized Placebo-Controlled HELP Trial
Daniel Burkhoff et al.
JACC-HEART FAILURE (2020)
Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
James M. Beattie et al.
OPEN HEART (2020)
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life
Tarek Bekfani et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Heart Failure With Preserved Ejection Fraction In Perspective
Marc A. Pfeffer et al.
CIRCULATION RESEARCH (2019)
Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology
Andreas B. Gevaert et al.
FRONTIERS IN PHYSIOLOGY (2019)
Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Sanjiv J. Shah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction A Randomized Controlled Trial
Yogesh N. V. Reddy et al.
CIRCULATION RESEARCH (2019)
Obesity and heart failure with preserved ejection fraction: a paradox or something else?
Marijana Tadic et al.
HEART FAILURE REVIEWS (2019)
Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis
Anna L. Beale et al.
OPEN HEART (2019)
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2018)
Systematic review of economic burden of heart failure
Asrul Akmal Shafie et al.
HEART FAILURE REVIEWS (2018)
Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction
Parin Shah et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
Johann Altenberger et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2018)
The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis
Selma Bouthoorn et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization
Satoshi Suzuki et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction The INDIE-HFpEF Randomized Clinical Trial
Barry A. Borlaug et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The efficacy and safety of soluble guanylate cyclase stimulators in patients with heart failure A systematic review and meta-analysis
Xiaoyu Zheng et al.
MEDICINE (2018)
Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction
Pieter Martens et al.
ACTA CARDIOLOGICA (2018)
Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension
Licette C. Y. Liu et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
Anders Jorsal et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Burkert Pieske et al.
EUROPEAN HEART JOURNAL (2017)
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure
Pedro Moliner et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction
Payman Zamani et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis
Muhammad Shahzeb Khan et al.
ESC HEART FAILURE (2017)
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Marit de Jong et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction Clinical Correlates and Association With Standard Heart Failure Severity Indices
David Snipelisky et al.
CIRCULATION-HEART FAILURE (2017)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION RESEARCH (2016)
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Gerasimos Filippatos et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction
Julio Nunez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
David M. Kaye et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction
John J. Lepore et al.
JACC-HEART FAILURE (2016)
Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study
Julio Nunez et al.
ESC HEART FAILURE (2016)
PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A12-week, randomized, double-blind, placebo-controlled trial
Kyung-Hee Kim et al.
AMERICAN HEART JOURNAL (2015)
Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial
Elke S. Hoendermis et al.
EUROPEAN HEART JOURNAL (2015)
Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
Margaret M. Redfield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Estado del hierro en la insuficiencia cardiaca crónica: impacto en síntomas, clase funcional y capacidad de ejercicio submáxima
Cristina Enjuanes et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2015)
Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction
Payman Zamani et al.
CIRCULATION (2015)
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population
Richard K. Cheng et al.
AMERICAN HEART JOURNAL (2014)
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
Michele Senni et al.
EUROPEAN HEART JOURNAL (2014)
The annual global economic burden of heart failure
Christopher Cook et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
PDE5 inhibitor sildenafil in the treatment of heart failure: A meta-analysis of randomized controlled trials
Xiao-Dong Zhuang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction
Robert J. Mentz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Implications of Coronary Artery Disease in Heart Failure With Preserved Ejection Fraction
Seok-Jae Hwang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
Kim Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure A Prospective, Randomized Study
Spyridon Deftereos et al.
JACC-HEART FAILURE (2014)
Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin Alfa Single-blind Randomized Clinical Trial of Safety and Efficacy
Mathew S. Maurer et al.
CIRCULATION-HEART FAILURE (2013)
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
Kazuhiro Yamamoto et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
Josep Comin-Colet et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction
Muaz M. Abudiab et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
RAnoLazIne for the Treatment of Diastolic Heart Failure in Patients With Preserved Ejection Fraction
Lars S. Maier et al.
JACC-HEART FAILURE (2013)
Renal Dysfunction in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction Impact of the New Chronic Kidney Disease-Epidemiology Collaboration Group Formula
Finlay A. McAlister et al.
CIRCULATION-HEART FAILURE (2012)
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
D. Nathanson et al.
DIABETOLOGIA (2012)
Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study
Kanan Patel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan
Zoltan Papp et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
Role of ranolazine in angina, heart failure, arrhythmias, and diabetes
Samuel Sossalla et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Johannes-Peter Stasch et al.
CIRCULATION (2011)
PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study
Marco Guazzi et al.
CIRCULATION-HEART FAILURE (2011)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2011)
Epidemiology and clinical course of heart failure with preserved ejection fraction
Carolyn S. P. Lam et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction
Dalane W. Kitzman et al.
CIRCULATION-HEART FAILURE (2010)
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION-HEART FAILURE (2010)
Treatment of Heart Failure With Normal Ejection Fraction An Inconvenient Truth!
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Modulation of Titin-Based Stiffness by Disulfide Bonding in the Cardiac Titin N2-B Unique Sequence
Anika Gruetzner et al.
BIOPHYSICAL JOURNAL (2009)
Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs
Martina Krueger et al.
CIRCULATION RESEARCH (2009)
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction
Hari K. Parthasarathy et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Hypoxic modulation of exogenous nitrite-induced vasodilation in humans
Abdul R. Maher et al.
CIRCULATION (2008)
The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction
G. W. K. Yip et al.
HEART (2008)
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Jon O. Lundberg et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Nitrite infusion in humans and nonhuman primates - Endocrine effects, pharmacokinetics, and tolerance formation
Andre Dejam et al.
CIRCULATION (2007)
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension
Gregory D. Lewis et al.
CIRCULATION (2007)
Chronic heart failure slows late sodium current in human and canine ventricular myocytes: Implications for repolarization variability
Victor A. Maltsev et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
George G. Sokos et al.
JOURNAL OF CARDIAC FAILURE (2006)
Mechanisms of diastolic dysfunction in heart failure
Barry A. Borlaug et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2006)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
K Cosby et al.
NATURE MEDICINE (2003)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness
C Neagoe et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2003)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Sarcoplasmic reticulum Ca2+/calmodulin-dependent protein kinase is altered in heart failure
T Netticadan et al.
CIRCULATION RESEARCH (2000)
分享论文
